Skip to content

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07062172
Enrollment
1753
Registered
2025-07-14
Start date
2025-05-08
Completion date
2028-12-31
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Driver Mutation, Lung Cancer

Brief summary

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Interventions

DIAGNOSTIC_TESTLow Dose CT Scan

Completed once after screening and eligibility is confirmed.

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Cohort A: Inclusion Criteria: * Current diagnosis of lung cancer with a driver mutation. * Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.) * Able and willing to give informed consent. * Able and willing to complete the screening questionnaire. Cohort A:

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frameDescription
Number of lung cancers found2 yearsDetermine the number of lung cancers found in low dose CT scans of first degree relatives of lung cancer patients with known driver mutations.

Secondary

MeasureTime frameDescription
Number of lung abnormalities detected2 yearsDetermine the number of lung abnormalities found from low dose CT scan of first degree relatives of lung c. after the initial low dose CT scan with findings of lung abnormalities.
Number and type of biopsies performed2 yearsDetermine the number and type of biopsies performed in follow up to the finding of a lung abnormalities after a low dose CT scan of first degree relatives of lung cancer patients with a known driver mutation.
Number of follow-up CT scans2 yearsDetermine the number of follow-up CT scans ordered for first degree relatives of lung cancer patients with a known driver mutation after the initial low dose CT scan with findings of lung abnormalities.
Number of Adverse Events related to study procedures and follow-up interventions2 yearsDetermine the number of Adverse Events, per CTCAE 5.0, related to study procedures and follow-up interventions of immediate family members of lung cancer patients with a known driver mutation with a finding of a lung abnormality from a low dose CT scan.
Stage of Lung Cancers Found2 yearsDetermine the stages of all lung cancers found in immediate family members of lung cancer patients with a known driver mutation.
Number and type of resections performed2 yearsDetermine the number and type of resections performed in follow up to the finding of a lung abnormality after a low dose CT scan of first degree relatives of lung cancer patients with a known driver mutation.

Countries

United States

Contacts

Primary ContactChao Family Comprehensive Cancer Center University of California, Irvine
ucstudy@uci.edu1-877-827-8839
Backup ContactUniversity of California Irvine Medical

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026